Dr. Alaa Alahmadi has been selected by MIT Technology Review as one of the Innovators Under 35 for 2022 (Biotechnology & Medicine, MENA), as she has been recognized for her PhD research at the University of Manchester in finding an easier way to monitor a symptomless heart condition that could save thousands of lives each year.